Barclays’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42K | Sell |
58,089
-42,878
| -42% | -$31K | ﹤0.01% | 3972 |
|
|
2025
Q1 | $87K | Sell |
100,967
-24,237
| -19% | -$20.9K | ﹤0.01% | 3737 |
|
|
2024
Q4 | $210K | Buy |
125,204
+19,030
| +18% | +$31.9K | ﹤0.01% | 3492 |
|
|
2024
Q3 | $303K | Buy |
106,174
+47,059
| +80% | +$134K | ﹤0.01% | 3280 |
|
|
2024
Q2 | $139K | Sell |
59,115
-17,979
| -23% | -$42.3K | ﹤0.01% | 3220 |
|
|
2024
Q1 | $227K | Sell |
77,094
-33,844
| -31% | -$99.7K | ﹤0.01% | 3275 |
|
|
2023
Q4 | $332K | Buy |
110,938
+60,392
| +119% | +$181K | ﹤0.01% | 3246 |
|
|
2023
Q3 | $160K | Sell |
50,546
-1,040
| -2% | -$3.29K | ﹤0.01% | 3127 |
|
|
2023
Q2 | $200K | Sell |
51,586
-14,456
| -22% | -$56K | ﹤0.01% | 3081 |
|
|
2023
Q1 | $182K | Buy |
66,042
+11,727
| +22% | +$32.3K | ﹤0.01% | 3205 |
|
|
2022
Q4 | $98K | Buy |
54,315
+10,778
| +25% | +$19.4K | ﹤0.01% | 3469 |
|
|
2022
Q3 | $92K | Sell |
43,537
-371
| -0.8% | -$784 | ﹤0.01% | 3445 |
|
|
2022
Q2 | $118K | Buy |
43,908
+2,392
| +6% | +$6.43K | ﹤0.01% | 3392 |
|
|
2022
Q1 | $180K | Buy |
+41,516
| New | +$180K | ﹤0.01% | 3378 |
|